API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.prnewswire.com/news-releases/antiseizure-drug-diacomit-now-approved-for-children-as-young-as-6-months-301628988.html
https://www.prnewswire.com/news-releases/pantherx-rare-announces-partnership-with-biocodex-for-the-distribution-of-diacomit-stiripentol-for-the-treatment-of-seizures-associated-with-dravet-syndrome-in-patients-2-years-of-age-and-older-taking-clobazam-301575862.html
https://www.prnewswire.com/news-releases/m8-pharmaceuticals-announces-license-of-exclusive-rights-for-diacomit-stiripentol-from-biocodex-sas-301376198.html
https://www.biospace.com/article/zogenix-given-go-ahead-to-resubmit-fintepla-to-fda-for-dravet-syndrome/
https://www.fiercebiotech.com/biotech/encoded-therapeutics-bags-104m-to-propel-precision-gene-therapy-for-dravet-syndrome
https://blogs.sciencemag.org/pipeline/archives/2019/02/04/2018-drug-approvals-a-closer-look?r3f_986=https://www.google.com/
https://www.prnewswire.com/news-releases/fda-approves-diacomit-stiripentol-for-the-treatment-of-seizures-associated-with-dravet-syndrome-ds-in-patients-2-years-of-age-and-older-taking-clobazam-300701663.html
http://www.pharmatimes.com/news/smc_accepts_4_new_medicines_1205064